Stay updated on Efgartigimod Safety & Efficacy in pSS Clinical Trial
Sign up to get notified when there's something new on the Efgartigimod Safety & Efficacy in pSS Clinical Trial page.

Latest updates to the Efgartigimod Safety & Efficacy in pSS Clinical Trial page
- ChecktodayChange DetectedPage revision updated from v3.5.3 to v3.5.4, indicating a new build/version of the ClinicalTrials.gov page. The provided changes show only the revision tag with no visible substantive content changes in the data provided.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now includes PubMed-linked study publication text in the Publications section, along with an informational note that it is auto-filled. The site revision indicator has been updated from v3.5.2 to v3.5.3.SummaryDifference0.3%

- Check29 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check36 days agoChange DetectedIQVIA Pty Ltd was added as a collaborator and Iqvia Pty Ltd was removed.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision updated to v3.5.0; previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page now displays Revision: v3.4.3 in the footer, replacing Revision: v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Efgartigimod Safety & Efficacy in pSS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efgartigimod Safety & Efficacy in pSS Clinical Trial page.